As for renal cell carcinoma (RCC), the clinical and pathological characteristics of the patients included in different studies have demonstrated that VISTA is predominantly expressed in CD45+ cells in para-tumor and tumor tissues. This evidence concerns the gene PTPRC and neoplasm.